SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Blackstone Infrastructure Strategies L.P. completed an unregistered private placement of approximately $173.3 million in limited partnership units across three classes (Class I, S, and D) to accredited investors and qualified purchasers under Section 4(a)(2) and Regulation D exemptions, diluting existing unitholders' ownership percentages.
View raw filing on EDGAR →The fund disclosed Transactional NAV per Unit as of April 30, 2026 (Class I: $29.08, Class S: $28.75, Class D: $28.98) and aggregate fund NAVs ($5.0 billion for BXINFRA, $272.0 million for BXINFRA Lux), establishing the pricing basis for unit transactions and reflecting the fund's asset valuation.
View raw filing on EDGAR →Blackstone Private Equity Strategies Fund entered into a Second Amendment to its credit facility, increasing aggregate commitments to $2.65 billion, extending maturity to May 25, 2029, and modifying key terms including interest rates and financial covenants. This material refinancing event affects the fund's capital structure and liquidity position.
View raw filing on EDGAR →The fund completed unregistered sales of limited partnership units totaling approximately $447.4 million in aggregate consideration to accredited investors and qualified purchasers under Section 4(a)(2) and Regulation D exemptions. The issuance across multiple unit classes and series represents a material capital-raising event affecting the fund's capitalization and ownership structure.
View raw filing on EDGAR →Palomar announced successful completion of reinsurance programs incepting June 1, 2026, including $421 million of incremental earthquake limit and increased full-year 2026 adjusted net income guidance, reflecting expanded reinsurance capacity and improved risk profile.
View raw filing on EDGAR →The filing discloses a declared distribution to shareholders of $0.1560 per share (gross) across three share classes, payable on June 3, 2026. While distribution declarations are routine for REITs and real estate investment trusts, this disclosure under Item 7.01 (Regulation FD Disclosure) rather than a standard earnings release or distribution announcement suggests it may carry material significance to investors assessing dividend sustainability and cash flow. However, the event does not fit cleanly into the more specific taxonomy categories (earnings_release, which typically includes full financial results; or other standard event types), making "other_material" the most appropriate classification.
View raw filing on EDGAR →The filing discloses a distribution declaration for multiple share classes with specific per-share amounts ($0.0423 gross), record and payment dates, and notably waives the stockholder servicing fee on Class D shares in perpetuity. While distribution declarations are routine for REITs, the perpetual waiver of Class D servicing fees is a material change to the fee structure that affects shareholder economics and is not a standard administrative disclosure.
View raw filing on EDGAR →Chase Issuance Trust completed a $1.25 billion securitization of credit card receivables on May 28, 2026, issuing Class A(2026-1) notes as part of the CHASEseries. While this is a significant financing transaction, it does not fit cleanly into the M&A activity category (which typically covers acquisitions, dispositions, mergers, or changes of control) nor any other more specific event type. The disclosure is material to investors as it represents a substantial capital markets transaction and refinancing activity, but the securitization structure and credit risk retention mechanics do not align with standard M&A or dilutive issuance classifications.
View raw filing on EDGAR →The filing discloses a declared distribution of $0.04326 per share (net of fees) across multiple share classes, payable June 10, 2026. While distribution declarations are routine for REITs and typically immaterial administrative disclosures, this Item 7.01 Regulation FD Disclosure suggests the company deemed the distribution announcement material enough to file an 8-K. The specific per-share amounts and payment details would affect investor assessment of yield and cash flow, making it material to shareholders, though it does not fit neatly into the standard event taxonomy.
View raw filing on EDGAR →This is a clear Item 5.07 disclosure of shareholder meeting results held on May 28, 2026. The filing presents voting tallies for four proposals: election of nine board directors, advisory approval of named executive officer compensation, ratification of KPMG LLP as independent auditor, and amendment of the 2019 Omnibus Incentive Compensation Plan. All proposals passed with substantial majorities, making this a routine but material shareholder governance disclosure.
View raw filing on EDGAR →The Fund disclosed its NAV per Class I share of $25.87 as of April 30, 2026, aggregate NAV of $1,039.0 million, portfolio composition of 171 companies with $2,076.9 million fair value, and leverage metrics of 1.20x debt-to-equity, providing investors with material information on the Fund's financial condition and risk profile.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from ProKidney Corp.'s 2026 Annual Meeting of Stockholders held on May 28, 2026. The filing reports voting outcomes for director elections (William F. Doyle, Alan M. Lotvin, and Brian J.G. Pereira) and ratification of Ernst & Young LLP as independent auditor, which are routine but material governance matters that affect investor understanding of board composition and audit oversight.
View raw filing on EDGAR →Celia Pelaz, Chief Operating Officer of Spire Global, Inc., has informed the Company of her resignation effective September 30, 2026. The departure of a C-suite executive overseeing significant operational improvements is material to investors' assessment of the registrant's leadership and operational continuity, even though the Company does not intend to replace the position and no disagreement is disclosed.
View raw filing on EDGAR →The fund disclosed an ongoing private placement of Common Shares under Section 4(a)(2) and Regulation D, with approximately $0.5 million in subscriptions received on May 1, 2026, and plans to continue monthly offerings at NAV. This represents a dilutive equity issuance material to investors assessing the fund's capital structure and share dilution.
View raw filing on EDGAR →The Board appointed Michael A. Rossi as Interim Chief Financial Officer and principal financial officer, effective May 29, 2026, with compensation of $375/hour via Monomoy Advisors LLC.
View raw filing on EDGAR →Marc Nash, Executive Vice President of R&D, Operations and Service, informed the Company on May 26, 2026 of his decision to depart effective June 5, 2026. This is a clear executive departure of a senior officer responsible for critical functions (R&D, Operations, Service). The departure of a named executive in a material operational role would affect a reasonable investor's assessment of the registrant's leadership and operational continuity.
View raw filing on EDGAR →ACADIA held its Annual Meeting on May 29, 2026, with shareholders voting on and approving multiple matters including the election of three Class I directors (James M. Daly, Edmund P. Harrigan, and Adora Ndu), advisory approval of named executive officer compensation, ratification of Ernst & Young LLP as auditor, and approval of an amendment to the 2024 Equity Incentive Plan increasing authorized shares by 5,209,670.
View raw filing on EDGAR →This Item 5.07 disclosure reports the complete tabulation of stockholder votes from Neumora's Annual Meeting of Stockholders held on May 27, 2026, covering four proposals: election of three Class III directors, ratification of Ernst & Young LLP as independent auditor, advisory vote on named executive officer compensation, and advisory vote on frequency of future compensation votes. The filing presents vote counts (For, Against, Withheld, Abstentions, and Broker Non-Votes) for each proposal, which is the standard format for shareholder vote results disclosures required under Item 5.07.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure reporting the results of FiscalNote's annual meeting of stockholders held on May 27, 2026. The filing presents voting results for four proposals: election of two Class I directors (Compton and Hwang), advisory approval of named executive officer compensation, frequency of future advisory compensation votes, and ratification of RSM US LLP as independent auditor. The tabular presentation of vote counts (For, Against, Abstain, Broker Non-Votes) is the standard format for shareholder vote result disclosures.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure of shareholder vote results from Equillium's 2026 Annual Meeting held on May 28, 2026. The filing reports voting outcomes on four proposals: election of directors (with Peter Colabuono not renominated and board size reduced from seven to six), approval of a reverse stock split authorization (1-for-2 to 1-for-20 ratio at board discretion), ratification of Crowe LLP as independent auditor, and approval to increase authorized common shares from 200 million to 400 million. These results are material to investors as they reflect shareholder decisions on governance, capital structure, and audit oversight.
View raw filing on EDGAR →Fidus Investment Corp entered into a Note Purchase Agreement on May 29, 2026, to sell $120.0 million in aggregate principal amount of unsecured notes in a private placement, with net proceeds of approximately $117.6 million to be used to refinance existing 2026 Notes. The Company also entered into a Registration Rights Agreement in connection with the issuance and sale of $6.625% Senior Unsecured Notes due June 1, 2029, representing a material debt financing and refinancing transaction affecting the Company's capital structure.
View raw filing on EDGAR →The filing discloses a monthly distribution declaration for a real estate investment trust (REIT), specifying gross and net per-share amounts ($0.1927 gross, varying net by share class) payable on June 18, 2026. While distribution announcements are routine for REITs, this disclosure under Item 7.01 (Regulation FD) rather than a dedicated Item suggests it may carry material significance to investors assessing the REIT's cash generation and dividend sustainability. However, the taxonomy lacks a specific "dividend_distribution" category, and the event does not fit cleanly into earnings_release (no financial results) or other defined types.
View raw filing on EDGAR →Antares Private Credit Fund declared a regular distribution of $0.1887 per share, payable June 29, 2026, affecting shareholder cash flow expectations.
View raw filing on EDGAR →The fund disclosed key performance metrics including NAV per share of $24.69 as of April 30, 2026, aggregate NAV of $802.8 million, a debt-to-equity ratio of 1.18x, and ongoing offering progress of $817 million raised through May 1, 2026.
View raw filing on EDGAR →The filing discloses the appointment of David Friedman as a Class III director effective May 22, 2026, which is the principal action. While the section also mentions Megan Boston's resignation from the Board (though she remains CFO and secretary), the appointment is the affirmative governance action that drives the disclosure. The grant of 35,000 stock options is ancillary compensation tied to the appointment. Board composition changes are material to investors assessing corporate governance.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure of shareholder vote results from Impinj's Annual Meeting held May 28, 2026. The filing reports voting outcomes on four proposals: election of seven directors, ratification of Ernst & Young LLP as auditor, advisory approval of named executive officer compensation, and approval of the 2026 Equity Incentive Plan. All proposals passed with substantial majorities, making this a material disclosure of governance outcomes that investors rely upon to assess board composition and compensation arrangements.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from Aveanna Healthcare's 2026 Annual Meeting of Stockholders held on May 29, 2026. The filing presents final voting tallies for three proposals: election of three Class II directors (Rodney D. Windley, Sam Weil, and Steven E. Rodgers), ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. This is a routine but material Item 5.07 disclosure required by SEC rules.
View raw filing on EDGAR →The filing discloses a spin-off and separation of First Tracks Biotherapeutics, Inc. from AnaptysBio, with distribution of First Tracks common stock to stockholders. While the Item 7.01 disclosure itself is limited to tax guidance (Form 8937), the underlying transaction—a material corporate separation and dividend distribution—is a significant capital structure event that would materially affect investor assessment. This does not fit neatly into ma_activity (which typically covers acquisitions/mergers rather than spin-offs), so other_material is most appropriate.
View raw filing on EDGAR →Xylem completed a $1 billion public offering of senior notes ($500M 2033 Notes at 5.200% and $500M 2036 Blue Notes at 5.450%), governed by a supplemental indenture dated May 29, 2026. The proceeds are earmarked for debt refinancing and general corporate purposes, representing a material capital structure event.
View raw filing on EDGAR →Stockholders voted at the Annual Meeting on four proposals: election of three Class II directors (Diane Biagianti, Diane Brink, and Karl-Thomas Neumann), advisory approval of named executive officer compensation, approval of an amendment to the 2021 Omnibus Equity Incentive Plan increasing shares reserved by 17,000,000, and ratification of KPMG LLP as independent auditor. All proposals passed with substantial majorities.
View raw filing on EDGAR →The Company is conducting a continuous private placement of Common Shares under Section 4(a)(2) and Regulation D, with approximately $3.4 million in subscriptions received on May 1, 2026, and an intention to continue monthly sales at NAV.
View raw filing on EDGAR →Entravision held its 2026 Annual Meeting of Stockholders with voting results on seven director elections, ratification of Deloitte & Touche as independent auditor, advisory approval of named executive officer compensation, and approval of an amendment to the 2004 Equity Incentive Plan increasing authorized shares by 6,000,000.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure of shareholder vote results from Alta Equipment Group's Annual Meeting of Stockholders held on May 29, 2026. The filing reports voting outcomes on four proposals: election of three Class II directors (Ryan Greenawalt, Andrew Studdert, Colin Wilson), ratification of Deloitte & Touche LLP as independent auditor, advisory approval of named executive officer compensation, and approval of the first amendment to the 2020 Omnibus Incentive Plan. All proposals passed with substantial majorities, making this a material disclosure of governance and compensation decisions approved by shareholders.
View raw filing on EDGAR →Navient completed a $500 million public offering of senior notes on May 29, 2026, entering into an Underwriting Agreement with major financial institutions including BofA Securities, Barclays, J.P. Morgan, and RBC Capital Markets. The transaction represents a material financing activity affecting the company's capital structure and liquidity.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from Novanta Inc.'s annual meeting held on May 28, 2026. The filing reports the outcomes of three proposals: election of nine directors, advisory approval of executive compensation, and appointment of Deloitte & Touche LLP as independent auditor. All three proposals passed with substantial majorities. This is a quintessential Item 5.07 disclosure and is material to investors as it confirms the composition of the board and auditor for the upcoming fiscal year.
View raw filing on EDGAR →This is a clear Item 5.07 disclosure of shareholder vote results from Neuronetics' Annual Meeting of Stockholders held on May 28, 2026. The filing reports final voting tallies for four proposals: election of seven directors, ratification of KPMG LLP as independent auditor, advisory approval of executive compensation, and approval of the 2026 Equity Incentive Plan. All proposals passed with majority support, and the disclosure is material as it reflects stockholder governance decisions affecting board composition, audit oversight, and equity incentive arrangements.
View raw filing on EDGAR →This is a clear Item 5.07 disclosure of shareholder vote results from a special meeting held on May 28, 2026. The filing reports the voting outcomes on the Merger Proposal to adopt and approve the Merger Agreement between FONAR Corporation and Parent/Merger Sub entities, with detailed vote tallies showing approval by the requisite majorities (Company Stockholder Approval: 13,124,769 for vs. 551,079 against; Disinterested Stockholder Approval and Section 203 Approval also obtained). The merger is material to investors as it represents a change of control transaction expected to close on June 3, 2026.
View raw filing on EDGAR →Kennedy-Wilson completed a $1.8 billion senior notes issuance by a financing subsidiary to support a pending merger with Kona Bidco/Merger Sub, led by the CEO and including Fairfax Financial Holdings. The notes are held in escrow pending merger consummation, with mandatory redemption if the merger fails by November 16, 2026, representing material acquisition financing.
View raw filing on EDGAR →The filing discloses a draw of $1.7 million under a $50 million revolving credit facility established on April 21, 2026 with Parkview Holdings One LLC. While Item 2.03 is the appropriate disclosure vehicle for creation of direct financial obligations, this particular event—the first draw under a previously disclosed credit facility—is a routine drawdown rather than a material new obligation event. The material event (the Loan Agreement itself) was disclosed on April 22, 2026; this May 26 draw is administrative follow-through. However, marked material=true because the $50 million facility and its use for general corporate purposes could be significant to investor assessment of the company's liquidity and capital structure.
View raw filing on EDGAR →Ms. Simantov resigned from the Board of Directors effective May 23, 2026. The disclosure centers on her departure from the board, with the Separation Agreement addressing transition matters (waiver of retainer fees, preservation of equity awards and indemnification rights). This is a clear board departure with no indication of disagreement, making it a material executive departure event.
View raw filing on EDGAR →Tenaya Therapeutics held its Annual Meeting of Stockholders on May 27, 2026, with shareholders voting on three proposals: election of three Class II directors (Amy Burroughs, Karah Parschauer, and Catherine Stehman-Breen), ratification of Deloitte & Touche LLP as independent auditor, and approval of the amended 2021 Equity Incentive Plan. All three proposals passed with substantial majorities.
View raw filing on EDGAR →The Company's 2021 Equity Incentive Plan was amended and restated, effective upon stockholder approval at the May 27, 2026 Annual Meeting, including a one-time increase of approximately 3% of outstanding shares (6,509,966 shares) to the share reserve, removal of the annual 4 million share cap on the evergreen provision while maintaining a 4% annual increase, and limitations on incentive stock options.
View raw filing on EDGAR →The filing discloses a material dispute between Cardiff Oncology and Nerviano Medical Sciences involving a license agreement termination and competing claims of material breach. Cardiff filed a lawsuit on May 19, 2026 seeking injunctive relief and declaratory judgment, and NMS responded with a termination notice on May 27, 2026 alleging breaches related to patent inventorship and failure to conduct development activities for onvansertib. While Item 1.01 nominally covers "Entry into a Material Definitive Agreement," the substance here is a material litigation and contractual dispute that would significantly affect a reasonable investor's assessment of the company's rights to key intellectual property and product development obligations.
View raw filing on EDGAR →American Airlines entered into a Twelfth Amendment to its credit agreement on May 29, 2026, refinancing $1,146.8 million in existing term loans and incurring an additional $703.2 million in incremental term loans, totaling $1,850 million in new debt maturing in 2033. This material debt refinancing and incremental borrowing transaction affects the company's capital structure and liquidity.
View raw filing on EDGAR →GrafTech entered into an Equity Distribution Agreement with Evercore to offer and sell up to $50 million of common stock through an "at the market offering" under Rule 415. This is a classic dilutive equity issuance arrangement that allows the company to raise capital by selling shares at market prices, which materially affects existing shareholders through potential dilution and is a significant financing event.
View raw filing on EDGAR →Gulf Resources received a Nasdaq delisting determination letter on May 26, 2026, for non-compliance with Listing Rule 5250(c)(1) due to failure to timely file its Form 10-Q for Q1 2026 and Form 10-K for 2025. The company has until June 22, 2026 to submit a compliance plan and until October 12, 2026 to regain compliance, or face delisting. This is a material disclosure of delisting risk that would significantly affect investor assessment of the registrant's continued trading status.
View raw filing on EDGAR →The filing discloses a press release announcing the Company's financial results for the quarterly period ended April 3, 2026, attached as Exhibit 99.1. This is a standard earnings release disclosure under Item 2.02, which is material to investors as it provides periodic financial performance information.
View raw filing on EDGAR →This disclosure describes entry into a Business Combination Agreement between SPAC Axiom Intelligence Acquisition Corp 1 and Terra Quantum AG, a Swiss company, involving a multi-step merger transaction resulting in a change of control and creation of a new public company (PubCo). The agreement specifies consideration including share exchanges, earnout provisions (up to 75 million shares), board composition, and customary closing conditions. This is a material acquisition/merger transaction requiring Item 1.01 disclosure and would materially affect investor assessment of the registrant.
View raw filing on EDGAR →The filing discloses financial results for the first fiscal quarter ended March 31, 2026, via a press release furnished as Exhibit 99.1 under Item 2.02. This is a standard quarterly earnings release, which is material to investors as it provides periodic financial performance data essential to assessing the registrant's operational and financial condition.
View raw filing on EDGAR →Oceanhawk Acquisition Corp. consummated its IPO on May 22, 2026, issuing 16,000,000 units at $10.00 per unit ($184 million gross proceeds), with underwriters exercising an over-allotment option for 2,400,000 additional units ($24 million). Simultaneously, the company completed private placements of 530,000 units ($5.3 million) to insiders and The Benchmark Company. While technically a SPAC IPO (a blank-check company), the disclosure centers on the issuance of equity securities—units comprising Class A ordinary shares and rights—generating substantial capital. This is classified as dilutive_issuance because the filing emphasizes the unregistered private placement component (Section 4(a)(2) exemption) alongside the public offering, and SPACs inherently involve dilutive equity issuance structures.
View raw filing on EDGAR →